Are Americans being ripped off by Medivation’s $129,000 cancer drug?

Nonprofits and now 12 congresspeople are petitioning the government to use a rarely-used right to revoke patents in the case of a prostate cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.